Press releases
- SynAct Pharma utser Anders Dyhr Toft, MD, PhD, till Chief Medical Officer
- SynAct Pharma Appoints Anders Dyhr Toft, MD, Ph.D., as Chief Medical Officer
- SynAct Pharma AB tillkännager ytterligare data från fas 2a-studien med AP1189 i Covid-19-infekterade patienter och påminner om telefonkonferensen för att diskutera resultaten
- SynAct Pharma AB Announces Additional Data from the Phase 2a Trial of AP1189 in Covid-19 Infected Patients and Reminds of Management Call to Discuss Results
